Phase I/II Trial of Adeno-Associated Virus–Mediated Alpha-Glucosidase Gene Therapy to the Diaphragm for Chronic Respiratory Failure in Pompe Disease: Initial Safety and Ventilatory Outcomes
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase I/II Trial of Adeno-Associated Virus–Mediated Alpha-Glucosidase Gene Therapy to the Diaphragm for Chronic Respiratory Failure in Pompe Disease: Initial Safety and Ventilatory Outcomes
Authors
Keywords
-
Journal
HUMAN GENE THERAPY
Volume 24, Issue 6, Pages 630-640
Publisher
Mary Ann Liebert Inc
Online
2013-04-10
DOI
10.1089/hum.2012.250
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural Insight into the Unique Properties of Adeno-Associated Virus Serotype 9
- (2012) M. A. DiMattia et al. JOURNAL OF VIROLOGY
- Inspiratory Muscle Strength Training in Infants With Congenital Heart Disease and Prolonged Mechanical Ventilation: A Case Report
- (2012) B. K. Smith et al. PHYSICAL THERAPY
- Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy
- (2011) C. M. van Gelder et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Merry Christmas for Patients with Hemophilia B
- (2011) Katherine P. Ponder NEW ENGLAND JOURNAL OF MEDICINE
- Rapidly Progressive Diaphragmatic Weakness and Injury during Mechanical Ventilation in Humans
- (2010) Samir Jaber et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D
- (2010) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- CRIM-negative infantile Pompe disease: 42-month treatment outcome
- (2010) Marianne Rohrbach et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience
- (2010) Anupam Chakrapani et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Gel-mediated Delivery of AAV1 Vectors Corrects Ventilatory Function in Pompe Mice With Established Disease
- (2010) Cathryn S Mah et al. MOLECULAR THERAPY
- Inspiratory muscle training in a child with nemaline myopathy and organ transplantation
- (2010) Barbara K. Smith et al. Pediatric Critical Care Medicine
- Acute Progression of Neuromuscular Findings in Infantile Pompe Disease
- (2010) T. Andrew Burrow et al. PEDIATRIC NEUROLOGY
- Diaphragm motor unit recruitment in rats
- (2010) Carlos B. Mantilla et al. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
- Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease
- (2009) Marc Nicolino et al. GENETICS IN MEDICINE
- Pulmonary complications of neuromuscular disease: A Respiratory mechanics perspective
- (2009) Julian Allen Paediatric Respiratory Reviews
- Neural deficits contribute to respiratory insufficiency in Pompe disease
- (2009) L. R. DeRuisseau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
- (2009) M. L. Brantly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
- (2008) William W. Hauswirth et al. HUMAN GENE THERAPY
- Pompe's disease
- (2008) Ans T van der Ploeg et al. LANCET
- Rapid Disuse Atrophy of Diaphragm Fibers in Mechanically Ventilated Humans
- (2008) Sanford Levine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Measurement of maximal inspiratory pressure in ventilated children
- (2008) Gopinathannair Harikumar et al. PEDIATRIC PULMONOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started